A closer look at “What to know about a new Lyme disease vaccine”, exactly as the source publishes it. A new Lyme disease vaccine is seeking FDA approval. Pfizer and Valneva, a French specialty vaccine company, say a Lyme disease vaccine they are developing has reduced infections by around 70% in clinical trials compared to placebo shots.
The new vaccine differs from most other vaccines, said Katelyn Jetelina, an epidemiologist and scientific communicator. This vaccine trains our body to make antibodies and when a tick bites us, it drinks our blood, it drink The full version stays on the original page, which this listing opens directly.